Correction
Correction
In an article on rapid HIV tests in the April 2005 issue of Hospital Employee Health, the explanation of the specificity and sensitivity of the tests was misstated. It should have stated that specificity identifies the number of false positives produced by the test. The whole blood version of OraQuick Advance produces no false positives (specificity=100%), and the plasma and oral fluid test produces one false positive for every 1,000 tests performed (specificity=99.9%). It will result in four false negatives per 1,000 tests (sensitivity=99.6%) in the whole blood and plasma versions, and seven false negatives per 1,000 (sensitivity=99.3%) for oral fluid.
The new Multi-Spot HIV-1/HIV-2 Rapid Test produces no false negatives (sensitivity=100%) and seven false positives per 10,000 tests (specificity=99.93%) for serum and nine false positives per 10,000 tests (specificity=99.91%) for plasma.
We apologize for the error.
In an article on rapid HIV tests in the April 2005 issue of Hospital Employee Health, the explanation of the specificity and sensitivity of the tests was misstated.Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.